RSG Pharma And Welness Centre

Palnat 75mg Capsule is used to treat patients with certain types of breast cancer (estrogen receptor-positive, human epidermal growth factor receptor 2-negative) which have spread to other organs. It is given together with hormonal anticancer therapies.

Palnat 75mg Capsule is used to treat patients with certain types of breast cancer (estrogen receptor-positive, human epidermal growth factor receptor 2-negative) which have spread to other organs. It is given together with hormonal anticancer therapies.

Abiratas 500mg Tablet is a hormonal treatment, not a chemotherapy drug. It is used to treat prostate cancer in adult men that has spread to other parts of the body. Abiratas 500mg Tablet stops your body from making testosterone. This can slow down the growth of prostate cancer.

Palbociclib is a prescription medication used in combination with hormonal therapy for the treatment of hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-) advanced or metastatic breast cancer. It functions as a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, which acts by blocking certain proteins that contribute to the growth and multiplication of cancer cells. 

Key Information

Brand Names and Generics: Palbociclib is the active component. It is commonly known by the brand name Ibrance, with generic versions also available under various names.

Usage: Palbociclib is always administered alongside other hormonal anticancer therapies, such as an aromatase inhibitor (e.g., letrozole) or fulvestrant.

Administration: Capsules should be taken with food at roughly the same time daily. Tablets can be taken with or without food. It is important not to open, crush, or chew capsules or tablets.

Monitoring: Regular blood tests are necessary during treatment to monitor blood cell counts, as a common side effect is a reduction in white blood cell counts (neutropenia). 

Important Precautions & Side Effects

Serious Side Effects: Seek immediate medical attention if you experience symptoms of serious infection (fever, chills), difficulty breathing, chest pain, unusual bleeding or bruising, or nosebleeds.

Common Side Effects: Frequent side effects include fatigue, nausea, diarrhea, hair loss/thinning, rash, decreased appetite, and mouth sores.

Drug Interactions:

Consumption of grapefruit or grapefruit juice should be avoided.

It is important to inform your doctor about all medications, vitamins, and herbal products being taken, particularly strong CYP3A4 inhibitors or inducers, as they can interact with palbociclib. St. John's wort should not be used.

Pregnancy/Breastfeeding: 

Everolimus 5 mg tablets are a prescription medication used to treat various cancers and to prevent the rejection of transplanted organs. This medication works as a kinase inhibitor (specifically, an mTOR inhibitor) and an immunosuppressant. 

Key Uses

Everolimus 5 mg is prescribed for several conditions, including: 

Cancer treatment:

Advanced hormone receptor-positive, HER2-negative breast cancer (in postmenopausal women, in combination with exemestane).

Advanced renal cell carcinoma (kidney cancer) that has progressed after other treatments.

Certain types of advanced neuroendocrine tumors (originating from the pancreas, stomach, intestines, or lungs) that are inoperable.

Tumors associated with Tuberous Sclerosis Complex (TSC), such as subependymal giant cell astrocytoma (SEGA) and renal angiomyolipoma.

Organ transplant rejection prevention:

Used with other medicines (like cyclosporine or tacrolimus) to prevent the body from rejecting a transplanted kidney or liver. 

Important Safety Information and Precautions

Prescription Only: Everolimus is available by prescription only and should be used under strict medical supervision.

Administration: Tablets should be swallowed whole with a glass of water, with or without food, but consistently at the same time each day (always with food or always without). Do not

What is Cabolong 40mg Tablet used for? Cabolong 40mg Tablet is used to treat certain cancers, such as kidney cancer (advanced renal cell carcinoma), liver cancer after sorafenib, and thyroid cancer that has spread and no longer responds to radioactive iodine.2 Jan 2026